Journal
JOURNAL OF IMMUNOLOGY
Volume 181, Issue 11, Pages 7699-7705Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.181.11.7699
Keywords
-
Categories
Funding
- Division of Intramural Research
- National Heart, Lung, and Blood Institute,
- National Institutes of Health
Ask authors/readers for more resources
Thymic stromal lymphopoietin (TSLP) is a cytokine produced by stromal cells, epithelial cells, and basophils that acts on dendritic cells, mast cells, and CD4(+) T cells. The receptor for TSLP contains a TSLP-specific receptor chain (TSLPR) and the IL-7R a-chain. Although IL-7 critically controls the expansion and survival of naive and memory CD8(+) T cells, an action for TSLP on CD8(+) T cells has not been reported. We now demonstrate that CD8(+) T cells express TSLPR and that TSLP activates both STAT5 and Akt and induces Bcl-2 in these cells. Correspondingly, TSLP increases CD8(+) T cell survival in vitro as well as in wild-type and T-depleted mice in vivo, without altering the homeostatic proliferation of these cells. Moreover, TSLP can maintain CD8(+) T cells even in the absence of IL-7. Thus, our data reveal that TSLP contributes to CD8(+) T cell homeostasis in both normal and lymphopenic conditions. The Journal of Immunology, 2008, 181: 7699-7705.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available